Ceva, a spin-off of Sanofi-Synthélabo, is the world’s 10th-largest veterinary laboratory.

As a partner to Ceva since 1999, EMZ successively supported the LBO led by the funds PAI Partners and Industri Kapital. In June 2007 EMZ arranged a series of financing transactions that enabled Ceva’s management to acquire a majority stake in the company. In June 2014, EMZ supported the Management of Ceva which reorganised its capital structure while retaining the control of the group.